MADISON BLACK: Open Payments
NPI 1538927249 · OVERLAND PARK, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$526 in 38 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $526
Food & beverage: $526
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 7 | $155 |
| PFIZER INC. | 18 | $136 |
| Lilly USA, LLC | 7 | $130 |
| AstraZeneca Pharmaceuticals LP | 2 | $42 |
| Novartis Pharmaceuticals Corporation | 1 | $19 |
| Novo Nordisk Inc | 1 | $16 |
| Collegium Pharmaceutical, Inc. | 1 | $14 |
| Merck Sharp & Dohme LLC | 1 | $14 |
Products named: Veozah, MOUNJARO, PAXLOVID, ELIQUIS, AIRSUPRA, NURTEC ODT, LEQVIO, Ozempic.
Industry payments across KS — which companies pay providers there.
